alexa [A new look at the history of tumor immunotherapy--for its fruitful future through overcoming the widespread cynicism].


Immunotherapy: Open Access

Author(s): Takeuchi S, Takeuchi S, Takeuchi S, Takeuchi S

Abstract Share this page

Abstract This review deals with a new look at the history of tumor immunotherapy by dividing that into four generations in the context of its recent scientific advance which gives a birth of a new paradigm to immunology and immunotherapy of human cancer. Tumor immunology was born in 1953 when the presence of tumor specific transplantation antigens was demonstrated in the animal models. All trials were nonsense in the 0 generation before its birth except for Coley's vaccine. The 1st generation (1953-1983) of immunotherapy after its birth was the period in which the nonspecific immunotherapy was enthusiastically attempted too much without knowledge of specific tumor immunity, only to result in the cynicism of tumor immunology and immunotherapy. After this, new important discoveries in tumor immunology have been followed successively in animal models, giving a scientific basis to immunotherapy of human cancer. The key discoveries in human tumor immunology, however, have been done since 1986 when first adoptive immunotherapy with autologous CTL from patient's tumor was attempted. Thus, immunotherapy from 1983 to 1986 and that from 1986 to present are separately reviewed in this paper as the 2nd generation and the 3rd generation, respectively.
This article was published in Hum Cell and referenced in Immunotherapy: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version